Niacin improves maturation and cryo-tolerance of bovine in vitro matured oocytes: An experimental study
Background: Nicotinic acid (niacin) is a broad-spectrum lipid-modifying agent that has potent antioxidant properties and reduces the production of lipid peroxidation.
Objective: The purpose of the present study was to investigate the maturation, embryo development and cryo-tolerance merit, and levels of malondialdehyde (MDA), total oxidant status, and total antioxidant capacity following the supplementation of bovine oocytes maturation medium with different concentrations of niacin.
Materials and Methods: Immature cumulus-oocyte complexes were cultured in tissue culture medium-199 maturation media supplemented with 0, 100, 200, and 400 µM niacin under a standard in vitro culture condition. After 24 hr of culture, the nuclear maturation rate was assessed. Then, two groups of immature cumulus-oocyte complexes were cultured in TCM-199 either with or without 400 µM niacin and evaluated for embryo development. Also, matured cumulus-oocyte complexes in both groups were frozen using a standard vitrification procedure. After vitrification, oocytes were warmed in two steps and evaluated for embryo development. In addition, the level of total antioxidant capacity, total oxidant status, and MDA were measured.
Results: The results indicated that although the treatment with 400µM niacin increased in vitro nuclear maturation (87.6 ± 5.3), it did not improved the embryo development to the blastocyst stage. Higher cleavage and blastocyst rates were observed in vitrified oocytes that were cultured with supplemented 400 µM niacin compared to the control group (without niacin) (53.6 ± 2.7 and 10.6 ± 1.6 vs. 46.2 ± 4.1 and 6.3 ± 2.4, respectively). Also, the addition of 400 µM niacin to the maturation media could decrease MDA levels after maturation.
Conclusion: Niacin could improve the quality of in vitro embryo production (IVP) embryos and tolerance of bovine oocytes to vitrification.
Key words: Bovine, Embryonic development, Niacin, Oocytes, Vitrification.
 Ali AA, Bilodeau JF, Sirard MA. Antioxidant requirements for bovine oocytes varies during in vitro maturation, fertilization and development. Theriogenology 2003; 59: 939–949.
 Pasqualotto EB, Agarwal A, Sharma RK, Izzo VM, Pinotti JA, Joshi NJ, et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril 2004; 81: 973–976.
 Bahmanpour S, Bakhtari A, Abouhamzeh B. Protective effect of vitrified-warmed media with clove bud (syzygium aromaticum) extract on mouse oocytes and resultant blastocysts. Cryo Letters 2018; 39: 288–297.
 Zare Z, Abouhamzeh B, Masteri Farahani R, Salehi M, Mohammadi M. Supplementation of L-carnitine during in vitro maturation of mouse oocytes affects expression of genes involved in oocyte and embryo competence: An experimental study. Int J Reprod BioMed 2017; 15: 779–786.
 de Matos DG, Herrera C, Cortvrindt R, Smitz J, Van Soom A, Nogueira D, et al. Cysteamine supplementation during in vitro maturation and embryo culture: a useful tool for increasing the efficiency of bovine in vitro embryo production. Mol Reprod Dev 2002; 62: 203–209.
 Brooks EL, Kuvin JT, Karas RH. Niacin’s role in the statin era. Expert Opin Pharmacother 2010; 11: 2291–2300.
 Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583–1592.
 Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. Clin Biochem 2007; 40: 623–628.
 Tupe RS, Tupe SG, Agte VV. Dietary nicotinic acid supplementation improves hepatic zinc uptake and offers hepatoprotection against oxidative damage. Br J Nutr 2011; 105: 1741–1749.
 Block J, Ruiz A, Reeg AM, Mamedova LK, Bradford BJ, Bilby TR, et al. Expression of niacin receptor GPR109A in bovine oocytes and preimplantation embryos and effect of addition of niacin during embryo culture on development following exposure to heat shock. J Sci Anim 2013; 96 (Suppl.): 590–591.
 Gandolfi F, Luciano AM, Modina S, Ponzini A, Pocar P, Armstrong DT, et al. The in vitro developmental competence of bovine oocytes can be related to the morphology of the ovary. Theriogenology 1997; 48: 1153–1160.
 Kafi M, Azari M, Chashnigir O, Gharibzadeh S, Aghabozorgi Z, Asaadi A, et al. Inherent inferior quality of follicular fluid in repeat breeder heifers as evidenced by low rates of in vitro production of bovine embryos. Theriogenology 2017; 102: 29–34.
 Divar MR, Kafi M, Mohammadi A, Azari M. The in vitro effect of adiponectin on early bovine embryonic development and transcriptomic markers of oocyte competence. JFIV Reprod Med Genet 2016; 4: 1–7.
 Fouladi-Nashta AA, Alberio R, Kafi M, Nicholas B, Campbell KH, Webb R. Differential staining combined with TUNEL labelling to detect apoptosis in preimplantation bovine embryos. Reprod Biomed Online 2005; 10: 497–502.
 Azari M, Kafi M, Ebrahimi B, Fatehi R, Jamalzadeh M. Oocyte maturation, embryo development and gene expression following two different methods of bovine cumulus-oocyte complexes vitrification. Vet Res Commun 2017; 41: 49–56.
 Chankitisakul V, Somfai T, Inaba Y, Techakumphu M, Nagai T. Supplementation of maturation medium with L-carnitine improves cryo-tolerance of bovine in vitro matured oocytes. Theriogenology 2013; 79: 590–598.
 Somfai T, Ozawa M, Noguchi J, Kaneko H, Kuriani Karja NW, Farhudin M, et al. Developmental competence of in vitro-fertilized porcine oocytes after in vitro maturation and solid surface vitrification: effect of cryopreservation on oocyte antioxidative system and cell cycle stage. Cryobiology 2007; 55: 115–126.
 Oborna I, Wojewodka G, De Sanctis JB, Fingerova H, Svobodova M, Brezinova J, et al. Increased lipid peroxidation and abnormal fatty acid profiles in seminal and blood plasma of normozoospermic males from infertile couples. Hum Reprod 2010; 25: 308–316.
 Aitken J, Fisher H. Reactive oxygen species generation and human spermatozoa: the balance of benefit and risk. Bioessays 1994; 16: 259–267.
 Oral O, Kutlu T, Aksoy E, Fıc¸ ıcıo ˘glu C, Uslu H, Tu˘ grul S. The effects of oxidative stress on outcomes of assisted reproductive techniques. J Assist Reprod Genet 2006; 23: 81–85.
 Kazemi A, Ramezanzadeh F, Nasr-Esfahani MH, Saboor Yaraghi AA, Ahmadi M. Does dietary fat intake influence oocyte competence and embryo quality by inducing oxidative stress in follicular fluid? Iran J Reprod Med 2013; 11: 1005–1012.
 Perumal SS, Shanthi P, Sachdanandam P. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria. Chem Biol Interact 2005; 152: 49–58.
 Chattopadhayay R, Ganesh A, Samanta J, Jana SK, Chakravarty BN, Chaudhury K. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest 2010; 69: 197–202.
 Oyawoye O, Abdel Gadir A, Garner A, Constantinovici N, Perrett C, Hardiman P. Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod 2003; 18: 2270–2274.
 Agarwal A, Allamaneni SS. Role of free radicals in female reproductive diseases and assisted reproduction. Reprod Biomed Online 2004; 9: 338–347.
 Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003; 9: 352–355.
 Martin PM, Ananth S, Cresci G, Roon P, Smith S, Ganapathy V. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol Vis 2009; 15: 362–372.
 Li X, Millar JS, Brownell N, Briand F, Rader DJ. Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Biochem Pharmacol 2010; 80: 1450–1457.
 Kang I, Kim SW, Youn JH. Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug. J Clin Endocrinol Metab 2011; 96: 3048–3055.
 Gloerich M, Bos JL. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 2010; 50: 355–375.